Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2001

01-05-2001 | Conference Report

Contralateral Breast Cancer: Molecular Differentiation Between Metastasis and Second Primary Cancer

Authors: Elisabeth Janschek, Daniela Kandioler-Eckersberger, Carmen Ludwig, Sonja Kappel, Brigitte Wolf, Susanne Taucher, Margaretha Rudas, Michael Gnant, Raimund Jakesz

Published in: Breast Cancer Research and Treatment | Issue 1/2001

Login to get access
Metadata
Title
Contralateral Breast Cancer: Molecular Differentiation Between Metastasis and Second Primary Cancer
Authors
Elisabeth Janschek
Daniela Kandioler-Eckersberger
Carmen Ludwig
Sonja Kappel
Brigitte Wolf
Susanne Taucher
Margaretha Rudas
Michael Gnant
Raimund Jakesz
Publication date
01-05-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1010661514306

Other articles of this Issue 1/2001

Breast Cancer Research and Treatment 1/2001 Go to the issue

Conference Report

Predictability of Monthly and Yearly Rhythms of Breast Cancer Features

Conference Report

Incidence of Second Primary Breast Cancer Among Women with a First Primary in Manitoba, Canada

Conference Report

Sealing of Postoperative Axillary Leakage After Axillary Lymphadenectomy Using a Fibrin Glue Coated Collagen Patch: a Prospective Randomised Study

Conference Report

p27 Expression Correlates with Short-Term, but not with Long-Term Prognosis in Breast Cancer

Conference Report

Induction of Anti-Mammary Cancer Immunity by Engaging the OX-40 Receptor in Vivo

Conference Report

Inhibition of Human Breast Cancer Cell Growth by Blockade of the Mevalonate-Protein Prenylation Pathway is not Prevented by Overexpression of Cyclin D1
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits